Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
1 February 2009
Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether the current approach by NICE to assessing cancer medicines…
New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?
1 November 2008
Australia was the first, in 1993, to make economic evaluation an important component of its decisions about reimbursement of drugs. Since then, several jurisdictions have followed…
Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds
1 October 2006
In June 2006, a conference entitled Better Analysis for Better Decisions: Bridging the Gap Between Economic Evaluation and Healthcare Decision-Making was held at McMaster University in…
What Could be Nicer than NICE?
1 August 2004
The National Institute for Clinical Excellence is the closest anyone has yet come to fulfilling the economist’s dream of how priority-setting in health care should be…
Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Developments
1 November 2003
The purpose of this book is to bring together a collection of papers by acknowledged experts in the field of trial-based health economic evaluation to provide…
From Efficacy to Cost-Effectiveness
1 May 1998
The advantage of such trials is high internal validity, i.e. relative freedom from dangers of confounding bias, as compared to other forms of research. Economic evaluations,…
Trends in Economic Evaluation
1 April 1998
The aim of this paper is to consider recent trends in the volume and characteristics of economic evaluation literature by interrogating the Health Economic Evaluations Database…
The Pros and Cons of Modelling in Economic Evaluation
1 May 1997
The participants were: Professor Bernard Bloom. University of Pennsylvania, USA Professor Martin Buxton. Director of the Health Economics Research Group, University of Brunel, UK Professor Michael…
Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
1 October 1996
The use of models in economic studies evaluating medicines and other health technologies has become a controversial issue. This is because study results now matter –…